Hermes International SA:企業の戦略・SWOT・財務分析

◆英語タイトル:Hermes International SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5249
◆発行会社(調査会社):MarketLine
◆発行日:2020年3月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Consumer Packaged Goods
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Hermes International SA – Strategy, SWOT and Corporate Finance Report
Summary

Hermes International SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Hermes International SA (Hermes) is a France-based company involved in designing, manufacturing and marketing of consumer goods. The company primarily offers bags, clutches, briefcases, luggage, small leather goods, diaries and writing objects, saddles, bridles, equestrian articles and apparel. It also offers fashion accessories including belts, gloves, hats, jewellery and foot wear. Hermes offers furniture and lighting, furnishing fabrics, ready-to-wear garments for men and women, wallpapers, decorative objects, tableware, carpets, silk and textiles, perfumes and watches.The company has its operations in Europe, the Middle East, Asia-Pacific and the Americas. Hermes is headquartered in Paris, France.

Scope

- Detailed information on Hermes International SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Hermes International SA in the form of a SWOT analysis
- An in-depth view of the business model of Hermes International SA including a breakdown and examination of key business segments
- Intelligence on Hermes International SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Hermes International SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Hermes International SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Hermes International SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Hermes International SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Hermes International SA: Company Overview
Hermes International SA: Overview and Key Facts
Hermes International SA: Overview
Hermes International SA: Key Facts
Hermes International SA: Key Employees
Hermes International SA: Key Employee Biographies
Hermes International SA: Major Products and Services
Hermes International SA: Company History
Hermes International SA: Management Statement
Hermes International SA: Locations and Subsidiaries
Hermes International SA: Key Competitors
Hermes International SA: Company Analysis
Hermes International SA: Business Description
Hermes International SA: SWOT Analysis
Hermes International SA: SWOT Overview
Hermes International SA: Strengths
Hermes International SA: Weaknesses
Hermes International SA: Opportunities
Hermes International SA: Threats
Hermes International SA: Corporate Financial Deals Activity
Hermes International SA: Financial Deals Overview
Hermes International SA: Targets and Partners
Hermes International SA: Top Deals 2016 – 2020YTD*
Hermes International SA: Mergers and Acquisitions
Hermes International SA: Recent Developments
Hermes International SA: News and Events Summary
Hermes International SA: Business Expansion
Hermes International SA: Contracts
Hermes International SA: Corporate Governance
Hermes International SA: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Hermes International SA: Key Facts
Table 2: Hermes International SA: Key Employees
Table 3: Hermes International SA: Company History
Table 4: Hermes International SA: Locations and Subsidiaries
Table 5: Hermes International SA: Key Competitors
Table 6: Hermes International SA: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Hermes International SA: Targets and Partners
Table 8: Hermes International SA: Top Deals 2016 - 2020YTD*
Table 9: Hermes International SA: M&A Volume and Value Trend (2016 - YTD*2020)
Table 10: Hermes International SA: M&A Activity by Geography (2016 - YTD*2020)
Table 11: Hermes International SA: News and Events Summary
Table 12: Hermes International SA: Business Expansion
Table 13: Hermes International SA: Contracts
Table 14: Hermes International SA: Corporate Governance
Table 15: Hermes International SA: Strategy and Operations

★海外企業調査レポート[Hermes International SA:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vectura Group Plc (VEC):企業の製品パイプライン分析
    Summary Vectura Group Plc (Vectura) is a formulation, device design and development company. It focuses on the development of inhaled airways products through an integrated inhaled drug delivery platform. Its major products include dry powder inhalers (DPI) and metered dose inhalers (MDI) for patien …
  • Besins Healthcare SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Besins Healthcare SA (Besins) is a pharmaceutical company that develops drugs for the well-being of men and women. The company offers AndroGel, a topical testosterone gel for hypogonadism. It also provides Oestrogel, a transdermal estradiol gel. Besins’ women's health products are used for t …
  • Northwell Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Northwell Health Inc (Northwell Health), formerly North Shore - Long Island Jewish Health System Inc, is a home health care service provider. The center offers services in the areas of anesthesiology and pain management, brain and nerve, cancer and blood disorder, child and teen health, diab …
  • CVR Energy Inc (CVI):石油・ガス:M&Aディール及び事業提携情報
    Summary CVR Energy Inc (CVR Energy) is a diversified holding company that specializes in refining of crude oil and manufacturing of nitrogen fertilizer. It produces and sells high value transportation fuels such as gasoline, diesel, jet fuel, and gas oil. The company also produces pet coke and other …
  • Sunshine Biopharma Inc (SBFM):製薬・医療:M&Aディール及び事業提携情報
    Summary Sunshine BioPharma Inc (Sunshine BioPharma), a subsidiary of Advanomics Corp is a pharmaceutical company that offers research, development and commercialization of drugs for treating cancer disease. The company provides generic and proprietary drugs for the treatment of cancer and other acut …
  • Rapid Pathogen Screening Inc:医療機器:M&Aディール及び事業提携情報
    Summary Rapid Pathogen Screening Inc (RPS) is a biotechnology company that designs, develops, manufactures and markets point-of-care diagnostic tests. The company uses its patented direct sampling micro-filtration and direct multi-planar chromafiltography (DMC) technology to develop various tests. I …
  • National Institute on Drug Abuse-製薬・医療分野:企業M&A・提携分析
    Summary National Institute on Drug Abuse (NIDA), a subsidiary of National Institutes of Health is a research institute that provides drug abuse and addiction services. The institute offers services in drugs of abuse such as bath salts, cocaine, heroin, inhalants, alcohol, club drugs, methamphetamine …
  • NUERNBERGER Beteiligungs-Aktiengesellschaft:企業の戦略・SWOT・財務情報
    NUERNBERGER Beteiligungs-Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary NUERNBERGER Beteiligungs-Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • BioElectron Technology Corp-製薬・医療分野:企業M&A・提携分析
    Summary BioElectron Technology Corp(BioElectron) formerly known as Edison Pharmaceuticals Inc, discovers and develops shared (redox) disease drugs. The company’s pipeline products comprise EPI-743, a drug candidate for inherited mitochondrial diseases and EPI-589 drug candidate entering phase 1 clin …
  • Molson Coors Brewing Co (TAP):企業の財務・戦略的SWOT分析
    Molson Coors Brewing Co (TAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Inflection Biosciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Inflection Biosciences Ltd (Inflection Biosciences) is a drug development company focused on discovery and development of small molecule therapeutics for the treatment of cancer. The company’s pipeline products include dual mechanism kinase inhibitors and pim kinase inhibitors including IBL- …
  • Azomures SA:企業の戦略的SWOT分析
    Azomures SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Oxeia Biopharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxeia Biopharmaceuticals Inc (Oxeia Biopharmaceuticals) is a clinical stage biotech company that develops drug treatments for mild traumatic brain injury or concussion and underlying neuro-metabolic dysfunction. The company’s lead pipeline candidate includes OXE-103, potent mitochondrial sta …
  • Busan Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Busan Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Busan Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Insys Therapeutics Inc (INSY)-製薬・医療分野:企業M&A・提携分析
    Summary Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems. The company’s flagship product, Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients. Its lead prod …
  • Aramex (ARMX):企業の財務・戦略的SWOT分析
    Summary Aramex, formerly Arab International Logistics (Aramex) Co PJSC is a transport and logistics service provider that offers supply chain solutions. The company offers solutions such as e-commerce, logistics, small business solutions, developers solutions center, drop and ship, shop and ship, am …
  • Intezyne Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Intezyne Inc (Intezyne) is a biotechnology company that develops product candidates for the treatment of various cancer tumors. The company offers anti-cancer agents and IVECT method to improve cancer therapy. It provides compounds that are cellular or molecularly targeted or have tumor-spec …
  • Intercontinental Hotels Group Plc:企業の戦略・SWOT・財務分析
    Intercontinental Hotels Group Plc - Strategy, SWOT and Corporate Finance Report Summary Intercontinental Hotels Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Pear Therapeutics Inc:企業の製品パイプライン分析2018
    Summary Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD) in conjunction with opioid replacement therapy; Thrive …
  • Carraro Spa:戦略・SWOT・企業財務分析
    Carraro Spa - Strategy, SWOT and Corporate Finance Report Summary Carraro Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆